Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data-Reference-Cited by-同舟云学术

Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data

Published:2021-06 Issue: Volume:97 Page:102191
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Barthélémy Philippe,Rioux-Leclercq Nathalie,Thibault Constance^ORCID,Saldana Carolina,Borchiellini Delphine,Chevreau Christine,Desmoulins Isabelle,Gobert Aurélien^ORCID,Hilgers Werner^ORCID,Khalil Ahmed,Lemoine Nathalie,Schlürmann-Constans Friederike,Négrier Sylvie

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference100 articles.

1. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma;Ricketts;Cell Rep.,2018

2. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours;Moch;Eur Urol.,2016

3. New and emerging renal entities: a perspective post-WHO 2016 classification;Trpkov;Histopathology,2019

4. Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial;Choueiri;Ann Oncol,2020

5. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma;Rini;N Engl J Med.,2019

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study;European Urology Oncology;2024-04

2. Identification of potential prognostic genes associated with the tumor microenvironment in chromophobe renal cell carcinoma based on weighted gene co-expression network analysis;2024-02-20

3. Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma;Canadian Urological Association Journal;2024-01-30

4. Patient and tumor characteristics of histological subtypes of renal cell carcinoma and its risk of upstaging to ≥pT3;Urologic Oncology: Seminars and Original Investigations;2023-12

5. Advances in non‐clear cell renal cell carcinoma management: From heterogeneous biology to treatment options;International Journal of Cancer;2023-10-12